Danish Bladder Cancer Register & Research Centre for Prevention and Health
Hermann GG, Steven K, Thind P, Mathiasen H, Jensen JB, Petersen A, et al. Danish Bladder Cancer Register. 2010 year report. Danish Bladder Cancer Register & Research Centre for Prevention and Health.
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update
Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011;59:997-1008.
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
DOI 10.1097/01.ju.0000125486.92260.b2
Sylvester R, Oosterlinck W, van der Meijden APM. A single immediate postoperative instillation of chemotherapy reduces the risk of recurrence in patients with stage Ta, T1 bladder cancer: a meta-analysis of published results of randomised clinical trials. J Urol 2004;171:2186-90. (Pubitemid 38625431)
Crosslinking of DNA by enzymatic or activated mitomycins and porfiromycins, bifunctionally alkylating antibiotics
Szybalski W, Lyer VN. Crosslinking of DNA by enzymatic or activated mitomycins and porfiromycins, bifunctionally alkylating antibiotics. Fed Proc 1964;23:946-57.
Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: An animal model
Hou JCT, Landas S, Wang CY, Shapiro O. Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model. Anticancer Res 2011;31:929-32.
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77.